Human Amyloid Beta 42 ELISA Kit is a Sandwich (quantitative) ELISA kit for the measurement of Human Amyloid Beta 42 in Human in Plasma, Tissue Homogenate, Serum, Other biological fluids samples.
Colorimetric
Plasma, Tissue Homogenate, Serum, Other biological fluids
Sandwich (quantitative)
Human
4.688 - 300 pg/mL
= 2.813 pg/mL
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application sELISA | Reactivity Reacts | Dilution info - | Notes - |
Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis (PubMed:25122912). Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(o) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1 (By similarity). By acting as a kinesin I membrane receptor, plays a role in axonal anterograde transport of cargo towards synapses in axons (PubMed:17062754, PubMed:23011729). Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1.Amyloid-beta peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to Cu(+) and Fe(2+), respectively. Amyloid-beta protein 42 is a more effective reductant than amyloid-beta protein 40. Amyloid-beta peptides bind to lipoproteins and apolipoproteins E and J in the CSF and to HDL particles in plasma, inhibiting metal-catalyzed oxidation of lipoproteins. APP42-beta may activate mononuclear phagocytes in the brain and elicit inflammatory responses. Promotes both tau aggregation and TPK II-mediated phosphorylation. Interaction with overexpressed HADH2 leads to oxidative stress and neurotoxicity. Also binds GPC1 in lipid rafts.Appicans elicit adhesion of neural cells to the extracellular matrix and may regulate neurite outgrowth in the brain.The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis.
A4, AD1, APP, Amyloid-beta precursor protein, APP, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II
Human Amyloid Beta 42 ELISA Kit is a Sandwich (quantitative) ELISA kit for the measurement of Human Amyloid Beta 42 in Human in Plasma, Tissue Homogenate, Serum, Other biological fluids samples.
Colorimetric
Plasma, Tissue Homogenate, Serum, Other biological fluids
Sandwich (quantitative)
Human
4.688 - 300 pg/mL
Microplate (12 x 8 well strips)
= 2.813 pg/mL
Sample | n | mean | SD | C.V. |
---|---|---|---|---|
Sample Overall | n 0 | mean - | SD - | C.V. < 8 |
Sample | n | mean | SD | C.V. |
---|---|---|---|---|
Sample Overall | n 0 | mean - | SD - | C.V. < 10 |
Blue Ice
+4°C
+4°C
+4°C
Human Amyloid Beta 42 ELISA kit (ab289832, E4288) is a sandwich ELISA assay for the quantitative measurement of human Amyloid Beta 42 in serum, plasma and cell culture supernatants. The density of color is proportional to the amount of human Amyloid Beta 42 captured from the samples.
This supplementary information is collated from multiple sources and compiled automatically.
Amyloid beta 42 also known as Aβ42 is a peptide fragment generated through the proteolytic processing of the amyloid precursor protein (APP) by enzymes called beta-secretase and gamma-secretase. The mass of Aβ42 is approximately 4.5 kDa. It is primarily expressed in the central nervous system specifically in the brain where it plays a role in the normal synaptic function. Although in low concentrations Amyloid beta 42 is involved in a variety of neural activities.
Amyloid beta 42 is an important component in the formation of amyloid plaques which are aggregates that occur extracellularly in the brain. These plaques are a major hallmark of Alzheimer's disease but generally Amyloid beta 42 can be found in both healthy and diseased brains. It is not part of a stable complex but it interacts with other types of amyloid beta peptides and possibly other molecular structures within the brain.
The production of Amyloid beta 42 is a central event in the amyloidogenic pathway which contributes to Alzheimer's disease pathogenesis. This pathway involves the sequential action of beta-secretase and gamma-secretase on APP. Aβ42 closely interacts with proteins like presenilin which are important components of the gamma-secretase complex influencing the proteolytic cleavage that determines the length of the amyloid beta peptides produced.
Amyloid beta 42 is most notably linked to Alzheimer's disease where it contributes to neuronal death and cognitive decline along with its strong association with amyloid plaques. Some evidence also indicates its involvement in other neurodegenerative diseases like cerebral amyloid angiopathy. In Alzheimer’s disease high levels of Amyloid beta 42 correlate with hyperphosphorylation of tau proteins another neuropathological feature which further drives the neurodegenerative process.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com